Lorazepan

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lorazepan

Property Description
Active ingredient Lorazepam (INN)
Form Tablet, Oral Solution, Injection Solution
Pharmacological class Benzodiazepine, Anxiolytic, Sedative-hypnotic
General purpose Reducing nervous tension and anxiety
Origin Synthetic Compound

What Type of Medicine is Lorazepan?

Lorazepan is the medicinal entity containing Lorazepam (INN), a synthetic compound classified as a benzodiazepine derivative, which functions as an anxiolytic (anti-anxiety) and a sedative-hypnotic agent. Lorazepam is a depressant substance and a member of the benzodiazepine class. This classification is clinically recognized for compounds used to quickly modulate central nervous system activity. Lorazepam is specifically valued among its class for being an intermediate-acting compound, offering a balance between rapid onset and moderate duration, a property often preferred for managing acute episodes of severe agitation or anxiety.


Composition and Pharmaceutical Forms of Lorazepam

The core chemical component and sole active ingredient of the product is Lorazepam, making it a single-ingredient product (monotherapy). This compound is provided as a pharmaceutical preparation in several dosage forms to accommodate varied clinical needs. These forms include the common oral tablet, the oral solution (often preferred for patients requiring adjustable dosing or difficulty swallowing), and a sterile injection solution intended for intramuscular or intravenous routes of administration. This range of presentation is crucial; for instance, the injection solution is specifically reserved for use in urgent situations where a rapid therapeutic effect is required.


How Does Lorazepam Produce a Calming Effect?

Lorazepam produces its characteristic effect by acting as a Central Nervous System (CNS) depressant, which reduces overall neural activity and brain excitability. It achieves this by enhancing the actions of the inhibitory neurotransmitter GABA (Gamma-aminobutyric acid), the body's natural signaling chemical for slowing down nerve impulses. By boosting this internal calming mechanism, Lorazepam’s fundamental purpose is to generate a profound sedative effect and anxiolytic effect, stabilizing states of nervous tension. Its clinical role includes the management of acute agitation and seizures, which confirms its utility in stabilizing excessive neural excitation.

Regulatory References

  1. WHO Essential Medicines List for Lorazepam

What side effects are possible with Lorazepan?

Possible Side Effects and Safety Information

The safety profile of Lorazepam is officially documented, defining the anticipated adverse reactions and required precautions based on regulatory data. The most Common adverse reactions documented in regulatory sources are generally related to the Central Nervous System (CNS).

Frequency and System-Organ Classes

The most frequent reactions observed in clinical use include sedation, somnolence (sleepiness), dizziness, ataxia (loss of coordination), and fatigue. These effects, classified as Common, are often more pronounced at the start of treatment or following dose increases. Uncommon adverse reactions include nausea and changes in libido. The official categorization of side effects involves several system-organ classes, including Nervous System Disorders, Psychiatric Disorders, and General Disorders.

Serious Safety Considerations

Regulatory agencies formally document the potential for less common, but serious, adverse reactions. These include respiratory depression (potentially fatal), severe hypersensitivity reactions such as anaphylaxis or angioedema (swelling of the throat), and the risk of blood dyscrasias or hepatic dysfunction. Furthermore, the regulatory label explicitly notes the potential for physical and psychological dependence, a risk that increases with higher doses and prolonged use.

Population-Specific Notes

The prescribing information includes specific safety guidance for certain patient groups. Older adults and debilitated patients are noted to be more susceptible to CNS side effects like sedation and ataxia. Caution is also warranted for individuals with compromised respiratory function due to the heightened risk of respiratory depression. The medicine is formally contraindicated in patients with known hypersensitivity to benzodiazepines or with acute narrow-angle glaucoma.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes lorazepam overdose as primarily causing dose-dependent Central Nervous System (CNS) depression.

Documented Overdose Manifestations

Symptoms of lorazepam overdose range from mild to severe and typically include:

  • Drowsiness and profound sedation
  • Confusion and disorientation
  • Ataxia (loss of coordination and unsteadiness)

Life-Threatening Outcomes

Severe overdosage carries the explicit risk of life-threatening complications, especially when lorazepam is combined with other CNS depressants, such as alcohol or opioids. The most serious documented outcomes are respiratory depression (slowed or difficult breathing), coma, and death.

Emergency Action Required

Urgent medical attention must be sought immediately if an overdose is suspected or if serious symptoms occur, including unresponsiveness, breathing problems, or collapse. Individuals should contact emergency medical services or a poison control center.

Management is primarily supportive care, focused on maintaining airway and vital signs. While a benzodiazepine antagonist, such as Flumazenil, may be used for reversal, official labeling notes that its administration carries a documented risk of precipitating acute, potentially life-threatening seizures in some patients, requiring close medical observation. Elderly or debilitated patients may be more susceptible to severe sedative effects.

Therapeutic Uses of Lorazepan

Lorazepam is commonly used in contexts marked by increased discomfort or tension that manifest as severe and disruptive symptoms. It is applied across therapeutic domains where temporary assistance in symptom stabilization is appropriate. It is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.


Key Therapeutic Applications

Lorazepam helps manage symptoms across conditions presenting with acute episodes, including severe anxiety disorders, assistance with acute psychomotor agitation, and supportive symptom management for continuous seizure activity, known as status epilepticus. Furthermore, it is applied in situations requiring temporary assistance, such as before certain medical procedures, and for supportive symptom management during acute alcohol withdrawal syndrome.

The use of this medication is relevant for easing symptoms that may become temporarily overwhelming. This medication provides support that helps ease the overall symptom burden, contributing to improved comfort during periods of heightened symptoms.


Symptom Focus: Relief for Tension and Agitation

Lorazepam is commonly used when symptoms intensify and supportive relief is needed for excessive nervous tension, restlessness, and convulsive movements. It supports the patient during difficult episodes by easing distress.

Regulatory References

  1. Lorazepam Tablet Label

Eligibility and Restrictions for Use

Who Can and Cannot Use Lorazepam: Official Regulatory Information

The eligibility profile for Lorazepam is defined by clear contraindications and population-specific restrictions documented in official regulatory labeling.

Contraindicated Populations

Use of Lorazepam is prohibited for individuals with known hypersensitivity to the drug or other benzodiazepines, acute narrow-angle glaucoma, Myasthenia Gravis, severe respiratory insufficiency, Sleep Apnoea Syndrome, or severe hepatic insufficiency (due to the risk of hepatic encephalopathy).


Age-Related and Conditional Eligibility

Population Group Regulatory Status
Adults Generally Eligible
Older Adults Requires reduced initial dose and close monitoring.
Children under 12 Use is typically not established for anxiety; exceptions for acute uses like status epilepticus may apply.
Impaired Organ Function Requires caution and monitoring in mild to moderate renal or hepatic impairment.
Pregnancy/Lactation Generally not recommended or contraindicated.

For addiction-prone individuals and those with compromised respiratory function, use is conditional and requires heightened surveillance, as stated in the prescribing information.

What should I know about interactions with other medicines?

The official interaction profile for Lorazepam is characterized by two primary domains: Pharmacodynamic and Pharmacokinetic interactions, all documented in government regulatory sources.

Pharmacodynamic Interactions

Co-administration with other Central Nervous System (CNS) depressants may lead to an enhanced sedative effect. The most serious officially documented interaction involves opioids, which is associated with a risk of profound sedation, respiratory depression, coma, and death due to the additive depressant effects. Concomitant intake of alcohol is not recommended, as it significantly enhances these CNS depressant effects. Other substances in this category include antipsychotics, hypnotics, and sedatives. Specific combinations, such as with clozapine, carry documented risks of marked sedation and respiratory compromise. In contrast, substances like theophylline or aminophylline may reduce the sedative effects of Lorazepam.

Pharmacokinetic Interactions

Interactions that alter Lorazepam’s metabolism primarily involve the inhibition of glucuronidation, its main clearance pathway. Valproate (valproic acid) and probenecid are documented to reduce the total clearance and increase the plasma concentration of Lorazepam. Regulatory prescribing information requires a dosage adjustment, typically a reduction of approximately 50%, when these substances are administered concurrently. Additionally, regulatory notes state that elderly or debilitated patients may exhibit increased susceptibility to the sedative effects when Lorazepam is combined with other CNS depressants.

Mechanism of Action

Lorazepam's action is defined by a mechanism of enhancing the brain's natural inhibitory signaling rather than acting directly as a neurotransmitter. This process ultimately reduces the rate of neural communication throughout the central nervous system (CNS).


Modulating the GABAA Receptor for Enhanced Inhibition

Lorazepam functions as a Positive Allosteric Modulator (PAM) by binding to a specific site on the GABAA receptor complex. This interaction alters the receptor's structure, increasing its sensitivity to the inhibitory neurotransmitter GABA. This increased sensitivity leads to an increased frequency of chloride ion ( Cl^-) channel openings, which is the critical step in the drug’s mechanistic cascade.


Cellular Hyperpolarization and Systemic Dampening

The resulting mass influx of negatively charged Cl^- ions causes neurons to become hyperpolarized, making them functionally less responsive to excitatory input. This modulation of neuronal activity is concentrated in CNS regions, such as the limbic system, and in pathways controlling muscle tone in the spinal cord. The overall physiological consequence is a reduction in the rate of neuronal discharge, resulting in a systemic state of lowered neuronal excitability across the CNS.

Dosage and Administration Information

How Lorazepam is Used: Administration Guidelines

Lorazepam administration is dictated by the specific clinical context, utilizing distinct routes, dosage forms, and timing. The medication is commonly administered via the oral route (tablet or solution) for routine use, while the intravenous (IV) or intramuscular (IM) injection routes are reserved for urgent, acute management.


Dosing and Scheduling Patterns

The dosage for adults is typically calculated to be administered in divided doses throughout the day for anxiety management, with a usual maintenance range of 2 to 6 mg daily. Alternatively, when used for insomnia, a single dose of 2 to 4 mg is specified for administration once daily at bedtime. For acute conditions, such as status epilepticus, the IV dose is generally 4 mg, administered slowly at a rate not to exceed 2 mg per minute.


Procedural and Duration Constraints

Oral forms of Lorazepam may be taken with or without food. If using the oral concentrate, it requires immediate dilution with a liquid or semi-solid food prior to intake. Treatment for non-urgent conditions is generally limited to a short duration (typically 2 to 4 weeks). Upon discontinuation, the dose must be gradually reduced (tapered) to minimize the risk of withdrawal effects. Furthermore, the initial starting dose for older and debilitated adults should be reduced by approximately 50% from the standard adult range.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lorazepam

The information presented here summarizes the structure and focus of available research on lorazepam. It describes what has been studied and what remains uncertain, based on published research patterns. It does not offer clinical advice, recommendations, or safety summaries, which are covered in other sections.

Evidence for Lorazepam's Use in Anxiety Disorders

Lorazepam was evaluated in research exploring how symptoms change over time in adults. Researchers have primarily used short-term randomized controlled trials (RCTs) and comparative studies, often including a placebo group, to examine how symptoms are measured over a defined time interval, typically a few weeks. These studies focused on measuring outcomes describing episodic or acute changes in anxiety symptoms using standardized rating scales and patient-reported outcomes describing perceived discomfort.

The findings describe how measurements evolved during the study period, including scores compared to baseline or placebo in the study groups. However, the follow-up durations were limited in most of the existing RCTs. Evidence is limited regarding long-term outcomes and the sustainability of these measured changes over periods longer than one month.

Evidence for Lorazepam in Treating Status Epilepticus

Research has explored lorazepam's application in emergency settings for acute, disruptive episodes of seizures. Studies primarily involve comparative RCTs where lorazepam was evaluated in research contexts with other substances. The primary measured outcomes research examined time to a specific measured endpoint related to seizure activity and the proportion of patients who achieved seizure termination within a specific timeframe. Follow-up durations were limited to the immediate post-seizure window (e.g., a few hours), meaning there is limited information for long-term outcomes.

Evidence in Specific Patient Populations

Research has explored the use of lorazepam in older adults (geriatric populations). Findings indicate soft, non-causal patterns suggesting that research examined outcomes related to balance and cognitive function in older adults. The overall research suggests that results apply only to the populations studied, and long-term effects are not fully established in this group.

For pediatric populations, lorazepam was observed in research involving children and adolescents, especially in the context of treating acute seizure episodes. The available data for certain groups remain insufficient or evidence is limited regarding the measured outcomes for anxiety in this population.

Key Studies & References

  1. Benzodiazepines for anxiety disorders: an updated meta-analysis and systematic review

Frequently Asked Questions (FAQ)

Common questions about Lorazepan (FAQ)


Q: How fast does Lorazepan start working after taking it?

Based on regulatory data, the medicine generally reaches its peak concentration in the blood plasma approximately 2 hours after being taken by mouth. This time indicates when the highest level of the medicine is in the blood.


Q: How long does the effect of Lorazepan usually last?

Following oral administration, the drug reaches its highest concentration in the blood plasma in approximately 2 hours. The effects of the injection form are noted in official prescribing information to be observed for periods of 6 to 8 hours.


Q: What does the half-life of Lorazepan mean for the user?

The mean half-life of the active drug in the blood is approximately 12 hours. The half-life refers to the time it takes for the concentration of the medication in the body to be reduced by half. This measurement provides information about the medicine’s duration of action and elimination rate.


Q: What are the main risks associated with long-term use of Lorazepan?

Official guidelines state that continuous long-term use is not recommended, and the effectiveness of use beyond four months has not been systematically established in studies. For individuals on long-term therapy, official documents state that periodic monitoring of specific laboratory tests, such as blood counts and liver function tests, is suggested.


Q: What is the difference between Lorazepan and Alprazolam?

Lorazepam is pharmacologically characterized by an intermediate half-life of approximately 12 hours. This intermediate half-life is one distinguishing pharmacological characteristic among benzodiazepines, which can affect metabolism and elimination from the body.


Q: Why do doctors prescribe Lorazepan instead of other benzodiazepines?

Differences in the half-life and specific metabolism are pharmacological properties that inform prescribing decisions by healthcare providers.


Q: Does Lorazepan help with muscle relaxation or tension?

As a Central Nervous System (CNS) depressant, the drug's mechanism of action involves modulating nerve pathways that control muscle tone in the spinal cord, aligning with its classification as a Central Nervous System (CNS) depressant.


Q: Is Lorazepan safe for people who have liver problems?

Official prescribing information states the medicine is for use with caution in people with severe hepatic insufficiency, which is when the liver cannot function properly. For other cases of mild to moderate liver problems, dosage reduction may be warranted in some cases.


Q: Does using Lorazepan affect the ability to drive or operate machinery?

Yes, official safety information explicitly warns that Lorazepam can cause sleepiness, dizziness, and slow motor skills. Because of these effects, the labeling warns against driving, operating heavy machinery, or performing other dangerous activities until the user understands how the medication affects them.


Q: Can Lorazepan affect memory or concentration?

Official documentation includes memory problems and difficulty concentrating among the reported side effects.


Q: Why is Lorazepan sometimes prescribed before surgery?

The injectable formulation of Lorazepan is formally indicated for pre-operative use. This is to provide sedation, relieve anxiety prior to the operation, and to produce a lack of recall of events related to the day of surgery.


Q: What happens if a person misses a dose of Lorazepan?

Official guidance regarding a missed dose depends on the purpose of use. Regulatory information describes a protocol for managing missed doses, which usually involves taking the dose within a certain time window for anxiety, or skipping it entirely for insomnia if already past the usual time. The guidance states that a double dose must not be taken.


Q: Can Lorazepan cause low blood pressure?

Low blood pressure (hypotension) is documented as an uncommon or serious adverse event in official adverse event listings associated with the use of the medicine.


Q: Is Lorazepan the same as Ativan?

Lorazepam is the generic name for the drug. Ativan is one of the common brand names under which the active ingredient, lorazepam, is commercially sold.


Q: Is there a generic version of Lorazepan available?

Yes, the name 'lorazepam' is the generic name (INN) of the active ingredient. The medicine is widely available in generic forms, as confirmed by regulatory drug lists.


Q: Does Lorazepan require a special controlled substance prescription?

Yes, according to the U.S. Drug Enforcement Administration (DEA), lorazepam is classified as a Schedule IV controlled substance. This classification indicates that the medicine has a recognized potential for physical and psychological dependence.


Q: Are there any specific foods that interact with Lorazepan?

According to official patient information, there are generally no known interactions between lorazepam and specific foods or non-alcoholic drinks. The medication can typically be taken with or without food.


Q: Can Lorazepan interact with herbal supplements like St. John's Wort or melatonin?

The official drug labeling advises patients to inform their healthcare provider about all herbal supplements they are taking. This information is requested by the labeling because non-prescription products, including herbal remedies, may have the potential to interact with Lorazepam.


Q: Can Lorazepan interact with common pain relievers like ibuprofen or acetaminophen?

Official patient labeling advises informing the healthcare provider about all over-the-counter (OTC) medicines, including common pain relievers. This precautionary measure is stated in the labeling because OTC products may have potential additive effects or interactions with Lorazepam.

How should Lorazepan be stored and disposed of?

Storage and Disposal Conditions for Lorazepam

The required storage conditions for Lorazepam vary by formulation.

Lorazepam tablets must be stored in a tightly closed container at Controlled Room Temperature, which is 68 F to 77 F (20 C to 25 C).

The Lorazepam oral solution requires specific environmental control: it must be stored and transported refrigerated at 36 F to 46 F (2 C to 8 C) and kept in its outer carton to protect from light. The oral solution container must be discarded after 30 or 90 days of first opening, depending on the volume.

All forms of Lorazepam must be stored out of the sight and reach of children.

Disposal instructions mandate that unused medicine must not be disposed of via wastewater or household waste but should be returned to a pharmacist or disposed of in accordance with local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lorazepan found in:

A-Z Index: